Bionik Laboratories Corp (BNKL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
| 03-2018 | 12-2017 | 09-2017 | 06-2017 | 03-2017 | |
| Sales | 417 | 261 | 222 | 88 | 17 |
| Cost of Goods | 225 | 88 | 60 | 29 | -17 |
| Gross Profit | 192 | 173 | 162 | 58 | 34 |
| Operating Expenses | 2,693 | 2,220 | 3,579 | 2,157 | 3,101 |
| Operating Income | -2,276 | -1,959 | -3,357 | -2,069 | -3,084 |
| Interest Expense | 0 | 0 | 0 | 0 | 20 |
| Other Income | -3,913 | -622 | -258 | -171 | 339 |
| Pre-tax Income | -6,189 | -2,581 | -3,615 | -2,241 | -2,764 |
| Net Income Continuous | -6,189 | -2,581 | -3,615 | -2,241 | -2,764 |
| Net Income | $-6,189 | $-2,581 | $-3,615 | $-2,241 | $-2,764 |
| EPS Basic Total Ops | -9.61 | -3.80 | -5.33 | -2.99 | -2.99 |
| EPS Basic Continuous Ops | -9.15 | -3.80 | -5.33 | -3.45 | -4.01 |
| EPS Diluted Total Ops | -9.61 | -3.80 | -5.33 | -2.99 | -2.99 |
| EPS Diluted Continuous Ops | -9.15 | -3.80 | -5.33 | -3.45 | -4.01 |
| EBITDA(a) | $-2,180 | $-1,861 | $-3,256 | $-1,952 | $-2,492 |